Text Size
167 studies found for:    lung cancer veterans affairs medical center

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine;   Drug: paclitaxel;   Drug: vinorelbine
2 Completed A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery
Condition: Lung Cancer
Interventions: Behavioral: smoking cessation intervention;   Drug: bupropion hydrochloride;   Drug: nicotine;   Procedure: psychosocial assessment and care
3 Active, not recruiting S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: irinotecan hydrochloride
4 Recruiting Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: celecoxib;   Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium;   Other: placebo
5 Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
6 Completed Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: cetuximab;   Drug: bortezomib;   Drug: docetaxel
7 Completed Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: irinotecan hydrochloride
8 Recruiting Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
9 Completed Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: docetaxel;   Drug: vinorelbine tartrate
10 Completed Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: BCG vaccine;   Biological: monoclonal antibody BEC2
11 Recruiting Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Procedure: therapeutic thoracoscopy;   Procedure: videothoracoscopy
12 Active, not recruiting S0126: Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: gefitinib
13 Active, not recruiting Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Dietary Supplement: selenium;   Other: placebo
14 Active, not recruiting Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: cixutumumab;   Drug: cisplatin;   Drug: etoposide phosphate;   Drug: vismodegib
15 Completed Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Procedure: conventional surgery
16 Completed Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: imatinib mesylate
17 Active, not recruiting S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: erlotinib hydrochloride
18 Unknown † Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: topotecan hydrochloride
19 Unknown † Collecting and Storing Samples From Patients With Lung Cancer
Condition: Lung Cancer
Intervention: Other: biologic sample preservation procedure
20 Completed Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: celecoxib;   Drug: gemcitabine hydrochloride;   Drug: zileuton
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years